Modelos europeos de telemedicina, como el servicio finlandés Medilux, permiten realizar consultas médicas online mediante un cuestionario clínico, sin acudir a una consulta presencial.

Bundle Branch Block and Need for Permanent Pacemaker, a Major Challenge after TAVR

Courtesy of Dr. Carlos Fava.

The development of new valves for TAVR and the increased experienced of operators have significantly decreased paravalvular leak. However, new bundle Branch block (BBB) and the need for permanent pacemaker (PPM) are still relatively high, and their impact and evolution remain controversial.  

Manejo quirúrgico o percutáneo de los leaks mitralesThe study looked at 816 patients, 437 with no conduction disturbances and 247 with BBB, 132 requiring PPM.

 

Mean age was 81, STS was 3.2%, and there were no differences between the groups.

 

At 30 days, there were no differences in mortality.


Read also: TAVR Is Feasible and Offers Good Outcomes in Patients with Cancer.


At 5 years, mortality was higher in the BBB group, followed by the PPM group, compared against patients with no conduction disturbances (48.4% vs. 46.7% vs. 328%, p=0,003). These differences started to show after one year.

 

Rehospitalization for heart failure was higher in patients presenting BBB and PPM, with no differences in hospitalization days between the 3 groups.


Read also: Percutaneous Closure Systems Are Safe in TAVR and Aneurysms.


There was a significant reduction in left ventricular ejection fraction in BBB and PPM patients, compared against patients with no conduction disturbances.

 

Conclusion

The development of BBB and the need for PPM is frequent after TAVR and they are associated to higher mortality risk and higher hospitalization rate due to heart failure.

 

Gentileza del Dr. Carlos Fava.

 

Original title: Mortality and Heart Failure Hospitalization in Patients With Conduction Abnormalities After Transcatheter Aortic Valve Replacement.

Reference: Troels H. Jørgensen, et al. (J Am Coll Cardiol Intv 2019;12:52–61.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

TAVI in TAVI: Clinical and Hemodynamic Outcomes According to the Type of Prosthesis Used in TAVI-in-TAVI

With the expansion of TAVI to younger and lower surgical risk patients, bioprosthetic valve degeneration and the need for repeat interventions are expected to...

Percutaneous Closure of Patent Foramen Ovale in Patients Over 60 Years Old With Cryptogenic Stroke: A Safe and Effective Strategy?

Cryptogenic stroke accounts for up to one-third of all ischemic strokes and remains strongly associated with the presence of a patent foramen ovale (PFO),...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroPCR 2026 | MELA Registry: Myval Showed Lower Aortic Regurgitation Rates in Patients With Large Aortic Annuli

This presentation, delivered by Dr. Salvatore Giordano at EuroPCR 2026, detailed the results of the MELA Registry, a multicenter study comparing the performance of...

EuroPCR 2026 | LANDMARK Trial: Two-Year Results Showed Comparable Efficacy Between Myval and Contemporary TAVI Valves

The LANDMARK trial presentation, delivered by Prof. Patrick W. Serruys at EuroPCR 2026, detailed the two-year clinical outcomes of contemporary transcatheter aortic valve implantation...

EuroPCR 2026 | 10-Year Left Main PCI: When Survival Is Similar, Should the Less Invasive Strategy Prevail?

The primary goal of revascularization in left main coronary artery disease (LMCA) is to improve survival. However, debate continues regarding whether, in anatomically suitable...